After a much-anticipated election and an action-packed lame-duck session, the 113th Congress has officially begun and The Senior Citizens League (TSCL) is gearing up for a busy year. Although the November election did not drastically alter the makeup on Capitol Hill, TSCL is expecting many new successes and challenges to arise. With the election finally behind them, lawmakers are able to focus on some of the complex policy issues that sit high on their agendas, like deficit reduction, immigration reform, and comprehensive tax reform. .While the cost of the prescription is affordable, the drug causes a number of serious side effects. Susan needs to see her doctor more frequently for monitoring and blood tests. Her biggest prescription cost surprise was learning that her prescription vitamin, folic acid, which she needs to fight the side effects, was not covered under Medicare. Her Part D plan wanted 0.00 for a one-month supply. Susan instead orders an over-the-counter supply of 400 pills for .99 on Amazon, taking 7 pills every day to get to the required dosage, which is still not as effective as the prescription version of folic acid. Now her doctor is considering a different medication. .Susan's mother started taking the prescription drug Eliquis last year, that will cost her mother about ,244 out-of-pocket in 2019 for that drug alone (she takes five other generics). Last year, the cost of Eliquis pushed her mom into the Part D doughnut hole where out-of-pocket costs were higher. Rising costs of the drug in 2019 will mean her mom will hit the doughnut hole a month sooner this year. .Sources: "Relief From Deportation: Demographic Profile Of The DREAMers Potentially Eligible Under The Deferred Action Policy," Migration Policy Institute, August 2012. .Some deficit cutters contend that the out-of-pocket costs that Medicare beneficiaries pay will have to go up and seniors should pay more for their Medicare benefits. "This survey is powerful testimony to those who hold such beliefs," says TSCL Chairman Larry Hyland. "This survey indicates that they don't understand how much seniors already spend for their healthcare, and how many have already cut back," Hyland adds. "With the majority of seniors depending on Social Security for at least half of their income, and healthcare costs increasing several times faster than benefits, few beneficiaries can afford to pay any more than they already do for their healthcare," he notes. .Proponents say that the change is needed because the CPI is inaccurate and doesn't reflect the effect on inflation when consumers substitute different types of lower-costing goods and services as prices increase. They argue that the government overpays Social Security beneficiaries because the current index is inaccurate and overstates inflation. .Four cosponsors signed on to the Social Security Fairness Act this week. Two Representatives – Ben Chandler (KY-6) and Mike Quigley (IL-5) – signed on to Rep. Buck McKeon's H.R. 1332, and two Senators – Sherrod Brown (OH) and Frank Lautenberg (NJ) – signed on to Sen. John Kerry's S. 20The cosponsor totals for these bills are up to 149 and 9, respectively. .The Senior Citizens League agrees with Senator Brown, and we oppose the proposal since it would negatively impact Social Security's finances and the retirement security of future beneficiaries. In the days ahead, Senator Marco Rubio (FL) and Senator Joni Ernst (IA) are expected to introduce the proposal as legislation, and TSCL's legislative team will monitor its movement closely. For updates, follow TSCL on Twitter or visit the Legislative News section of our website. .The President believes tying drug prices in the U.S. to those in other countries will bring down the prices here. However, the effect of his order won't be seen for some time and will only cover certain prescription drugs. The executive order requires that the secretary of Health and Human Services immediately test a payment model for Medicare to pay "no more than the most-favored-nation price," meaning the lowest price paid in other developed countries, for specific "high-cost" prescription drugs and products.